Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
drug launch
Pharma
Italfarmaco wins FDA's blessing for nonsteroidal DMD therapy
Privately held Italian drugmaker Italfarmaco has added a new treatment to the armamentarium against Duchenne muscular dystrophy.
Fraiser Kansteiner
Mar 22, 2024 11:05am
Kyowa's Orchard hopes $4.25M gene therapy price tag bears fruit
Mar 20, 2024 10:40am
Viatris, Mapi's long-acting MS drug rebuffed by FDA
Mar 11, 2024 11:11am
Amid launch hurdles, Eisai updates Leqembi's sales forecast
Mar 7, 2024 11:29am
Sandoz wins FDA nods for first Prolia, Xgeva biosimilars
Mar 6, 2024 9:52am
Formosa snags FDA nod for reformulation of decades-old steroid
Mar 5, 2024 11:36am